User profiles for Tadashi Kobayashi

Tadashi Kobayashi, MD, PhD

Hirosaki University School of Medicine & Hospital
Verified email at hirosaki-u.ac.jp
Cited by 587

Nuclear factor of activated T cells (NFAT) as a molecular target for 1α, 25-dihydroxyvitamin D3-mediated effects

A Takeuchi, GS Reddy, T Kobayashi… - The Journal of …, 1998 - journals.aai.org
The molecular basis of the immunomodulatory properties of 1α, 25-dihydroxyvitamin D 3 (1α,
25 (OH) 2 D 3) remains elusive. We demonstrate here that 1α, 25 (OH) 2 D 3-mediated …

Augmented very low frequency component of heart rate variability during obstructive sleep apnea

…, R Sasanabe, I Hirota, M Maekawa, T Kobayashi - Sleep, 1996 - academic.oup.com
After documenting the presence of obstructive sleep apnea syndrome (OSAS) through
polysomnography monitoring, we performed simultaneous ambulatory recordings of …

Observation of heavy cosmic-ray primaries over the wide energy range from∼ 100 GeV/particle to∼ 100 TeV/particle: Is the celebrated ''knee''actually so prominent?

…, E Kamioka, K Kirii, M Kitazawa, T Kobayashi… - Physical Review D, 1993 - APS
We have exposed a new type of emulsion chamber of area 1.53 m 2 at an atmospheric
depth of 11.7 g/cm 2 for 22.2 h. The chamber makes extensive use of screen-type x-ray films, …

Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review

T Kobayashi, T Ichiba, T Sakuyama, Y Arakawa… - Breast cancer, 2012 - Springer
Background Metastatic breast cancer (MBC) is generally incurable. However, 10–20-year
relapse-free survival of MBC is approximately 2%, implying that at least a small subset of MBC …

Comparison of opioid prescribing patterns in the United States and Japan: primary care physicians' attitudes and perceptions

E Onishi, T Kobayashi, E Dexter… - The Journal of the …, 2017 - Am Board Family Med
Introduction: Far fewer opioids are prescribed in Japan than in the United States. Methods:
We conducted an online physician survey assessing attitudes and perceptions that might …

[PDF][PDF] Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer

…, M Toi, Y Ito, S Noguchi, T Kobayashi… - Journal of clinical …, 2007 - academia.edu
Purpose To evaluate the efficacy and tolerability of dofequidar plus cyclophosphamide,
doxorubicin, and fluorouracil (CAF) therapy in comparison with CAF alone, in patients with …

Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas

T Okamoto, T Kobayashi… - … Medicinal Chemistry-Anti …, 2005 - ingentaconnect.com
The normalization of plasma alanine aminotransferase (ALT) has been proved to be a strategy
for preventing the development of hepatocellular carcinoma (HCC) in hepatitis C virus (…

Diacetonitrilebis (β-diketonato) ruthenium (II) complexes. Their preparation and use as intermediates for the synthesis of mixed-ligand β-diketonato ruthenium (III) …

T Kobayashi, Y Nishina, K Shimizu, GP Satô - Chemistry Letters, 1988 - academic.oup.com
Diacetonitrilebis(β-diketonato)ruthenium(II) complexes were readily prepared by reducing
the corresponding tris(β-diketonato)ruthenium(III) with zinc amalgam in an acetonitril–ethanol–…

EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer

H Nogi, T Kobayashi, M Suzuki, I Tabei… - Oncology …, 2009 - spandidos-publications.com
We retrospectively analyzed the expression of epidermal growth factor receptor (EGFR) as
a prognostic marker to predict neoadjuvant chemotherapy response and survival among …

[HTML][HTML] Regulation of type II renal Na+-dependent inorganic phosphate transporters by 1, 25-dihydroxyvitamin D3: identification of a vitamin D-responsive element in …

…, S Tatsumi, N Tsugawa, T Okano, T Kobayashi… - Journal of Biological …, 1998 - ASBMB
Vitamin D is an important regulator of phosphate homeostasis. The effects of vitamin D on the
expression of renal Na + -dependent inorganic phosphate (P i ) transporters (types I and II) …